Apoptotic Induction with Bifunctional E.coli Cytosine Deaminase-Uracil Phosphoribosyltransferase Mediated Suicide Gene Therapy is Synergized by Curcumin Treatment In vitro
- 311 Downloads
Development of novel suicide gene therapy vector with potential application in cancer treatment has a great impact on human health. Investigation to understand molecular mechanism of cell death is necessary to evaluate the therapeutic application of suicide vectors. For example, the bifunctional E.coli cytosine deaminase & uracil phosphoribosyltransferase fusion (CD-UPRT) gene expression is known to sensitize a wide range of cells toward nontoxic prodrug 5-flurocytosine (5-FC) by converting it to toxic compounds, but the exact pathway of cell death is yet to be defined. Herein, we investigated the mechanism of cell death by 5-FC/CD-UPRT suicide system in both cancer and non-cancer cells and found that the optimum 5-FC concentration led to programmed cell death in vitro. The CD-UPRT expression of transfected cells was measured by the RT-PCR analysis. Biochemical assays, such as mitochondrial activity (MTS) and lactate dehydrogenase (LDH) measurements exhibited cell death. Microscopic experiments showed characteristic onset of apoptosis which was further supported by internucleosomal DNA cleavage of BrdU labeled cellular DNA, appearance of characteristic laddering of chromosomal DNA and involvement of caspase pathway. Furthermore, the 5-FC/CD-UPRT-mediated apoptosis was potentiated with addition of a known anticancer agent curcumin. Our in vitro studies confirmed synergistic induction of apoptotic pathway in the combination treatment. Therefore, combination of 5-FC/CD-UPRT with curcumin could be a potential chemosensitization strategy for cancer treatment.
KeywordsSuicide gene therapy Apoptosis CD-UPRT 5-FC Curcumin
This research work was supported by the Department of Biotechnology [BT/PR9988/NNT/28/76/2007], Council of Scientific and Industrial Research [No.37 (1248)/06/EMR-II] Government of India. Assistance from Central instruments facility (CIF) IIT Guwahati, for confocal and SEM analysis is gratefully acknowledged. We are also thankful to Dr. Mitali Chatterjee (Department of Pharmacology, Institute of Postgraduate Medical Education & Research, Kolkata, India) for her help and suggestions.
- 5.Kurozumi, K., Tamiya, T., Ono, Y., Otsuka, S., Kambara, H., Adachi, Y., Ichikawa, T., Hamada, H., & Ohmoto, T. (2004). Apoptosis induction with 5-fluorocytosine/cytosine deaminase gene therapy for human malignant glioma cells mediated by adenovirus. Journal of Neuro-Oncology, 66, 117–127.PubMedCrossRefGoogle Scholar
- 7.Kambara, H., Tamiya, T., Ono, Y., Ohtsuka, S., Terada, K., Adachi, Y., Ichikawa, T., Hamada, H., & Ohmoto, T. (2002). Combined radiation and gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes. Cancer Gene Therapy 9, 840–845.PubMedCrossRefGoogle Scholar
- 14.Xia, K., Liang, D., Tang, A., Feng, Y., Zhang, J., Pan, Q., Long, Z., Dai, H., Cai, F., Wu, L., Zhao, S., Chen, Z., & Xia, J. (2004). A novel fusion suicide gene yeast CDglyTK plays a role in radio-gene therapy of nasopharyngeal carcinoma. Cancer Gene Therapy, 11, 790–796.PubMedCrossRefGoogle Scholar
- 15.Miyagi, T., Koshida, K., Hori, O., Konaka, H., Katoh, H., Kitagawa, Y., Mizokami, A., Egawa, M., Ogawa, S., Hamada, H., & Namiki, M. (2003). Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system. Journal of Gene Medicine, 5, 30–37.PubMedCrossRefGoogle Scholar
- 26.Maruyama-Tabata, H., Harada, Y., Matsumura, T., Satoh, E., Cui, F., Iwai, M., Kita, M., Hibi, S., Imanishi, J., Sawada, T., & Mazda, O. (2000). Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer. Gene Therapy 7, 53–60.PubMedCrossRefGoogle Scholar
- 27.Kanduc, D., Mittelman, A., Serpico, R., Sinigaglia, E., Sinha, A. A., Natale, C., Santacroce, R., Di Corcia, M. G., Lucchese, A., Dini, L., Pani, P., Santacroce, S., Simone, S., Bucci, R., & Farber, E. (2002). Cell death: Apoptosis versus necrosis (review). International Journal of Oncology, 21, 165–170.PubMedGoogle Scholar
- 32.Dorai, T., Cao, Y., Dorai, B., Buttyan, R., & Katz, A. E. (2001). Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. The Prostate 47, 293–303.PubMedCrossRefGoogle Scholar
- 34.Khor, T. O., Keum, Y., Lin, W., Kim, J., Hu, R., Shen, G., Xu, C., Gopalakrishnan, A., Reddy, B., Zheng, X., Conney, A. H., & Kong, A.T. (2006). Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Research, 66, 613–621.PubMedCrossRefGoogle Scholar
- 36.Khatri, A., Zhang, B., Doherty, E., Chapman, J., Ow, K., Pwint, H., Wilks, R. M., & Russell, P. J. (2006). Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice. Journal of Gene Medicine, 8, 1086–1096.PubMedCrossRefGoogle Scholar